Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway - Liu, Mengguo; Yang, Ji; Xing, Xiaojing; Cui, Xiangxiang; Li, Ming (Arthritis research & therapy, 2014)
Keywords: Adult; Biotechnology industry; Cells, Cultured; Development and progression; Female; Humans; Interleukin-17 - administration & dosage; Interleukin-17 - physiology; Male; MAP Kinase Signaling System - drug effects; MAP Kinase Signaling System - physiology; Middle Aged; Muscle, Smooth, Vascular - drug effects; Muscle, Smooth, Vascular - enzymology; Myocytes, Smooth Muscle - drug effects; Myocytes, Smooth Muscle - enzymology; Physiological aspects; Protein kinases; Scleroderma (Disease); Scleroderma, Systemic - enzymology; Scleroderma, Systemic - pathology; Systemic scleroderma; United States; China